Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.49 NOK | -3.67% | +3.20% | -27.62% |
May. 14 | Transcript : Nykode Therapeutics AS, Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Nykode Therapeutics AS Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 140M 13.24M | Sales 2025 * | 191M 18.11M | Capitalization | 5.06B 479M |
---|---|---|---|---|---|
Net income 2024 * | -612M -58M | Net income 2025 * | -740M -70.13M | EV / Sales 2024 * | 27.3 x |
Net cash position 2024 * | 1.25B 118M | Net cash position 2025 * | 1.01B 95.29M | EV / Sales 2025 * | 21.2 x |
P/E ratio 2024 * |
-8.28
x | P/E ratio 2025 * |
-7.42
x | Employees | 172 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 55% |
Latest transcript on Nykode Therapeutics
1 day | -3.67% | ||
1 week | +3.20% | ||
Current month | -1.84% | ||
1 month | +11.92% | ||
3 months | -2.33% | ||
6 months | -13.56% | ||
Current year | -27.62% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 47 | 06-12-31 | |
Michael Engsig
CEO | Chief Executive Officer | - | 07-02-28 |
Harald Gurvin
DFI | Director of Finance/CFO | 49 | 21-05-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bernd Seizinger
BRD | Director/Board Member | 67 | - |
Director/Board Member | 64 | - | |
Director/Board Member | - | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 746 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - | |
0.00% | 146 M€ | -1.29% | - | |
0.00% | 25 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 15.49 | -3.67% | 559,166 |
24-06-03 | 16.08 | +1.90% | 950,593 |
24-05-31 | 15.78 | +8.53% | 3,752,664 |
24-05-30 | 14.54 | -0.14% | 498,970 |
24-05-29 | 14.56 | -3.00% | 739,643 |
Real-time Oslo Bors, June 04, 2024 at 10:45 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.62% | 478M | |
+16.73% | 123B | |
+13.04% | 107B | |
-5.80% | 24.01B | |
+1.69% | 22.59B | |
-10.09% | 18.16B | |
-40.52% | 16.84B | |
-14.00% | 16.23B | |
+1.18% | 13.43B | |
+24.18% | 11.32B |
- Stock Market
- Equities
- VACC Stock